Advisor Group Holdings, Inc. Aspira Women'S Health Inc. Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.32 - $0.58 $2,109 - $3,822	6,591 Added 11.8%	62,451 $23,000
Q4 2022 Feb 10, 2023	BUY	$0.3 - $0.41 $3,963 - $5,416	13,212 Added 30.98%	55,860 $18,000
Q3 2022 Nov 14, 2022	BUY	$0.38 - $1.07 $13,215 - $37,212	34,778 Added 441.91%	42,648 $16,000
Q2 2022 Aug 10, 2022	BUY	$0.4 - $1.09 $1,147 - $3,126	2,868 Added 57.34%	7,870 $4,000
Q1 2022 May 04, 2022	SELL	$0.88 - $1.81 $3,230 - $6,644	-3,671 Reduced 42.33%	5,002 $5,000
Q3 2021 Nov 05, 2021	BUY	$3.19 - $5.48 $6,861 - $11,787	2,151 Added 32.98%	8,673 $29,000
Q2 2021 Aug 02, 2021	BUY	$4.78 - $6.84 $4,971 - $7,113	1,040 Added 18.97%	6,522 $36,000
Q1 2021 May 13, 2021	SELL	$5.9 - $9.13 $3,817 - $5,907	-647 Reduced 10.56%	5,482 $37,000
Q4 2020 Feb 10, 2021	BUY	$3.0 - $6.71 $3,387 - $7,575	1,129 Added 22.58%	6,129 $41,000
Q3 2020 Nov 12, 2020	SELL	$2.54 - $4.56 $12,700 - $22,799	-5,000 Reduced 50.0%	5,000 $15,000
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $7,800 - $52,500	10,000 New	10,000 $38,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.